Tevogen Inc.
Organization details
- Legal name
- Tevogen Inc.
- Former names
- Tevogen Bio Holdings Inc. Semper Paratus Acquisition Corp
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Warren
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- TVGN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001860871
- EIN
- 98-1597194
Board of directors
-
Avinash R. Wadhwani · DirectorSince 2023
-
Curtis L. Patton · DirectorSince 2024
-
Donald G. Fell · DirectorSince 2023
-
Jeffrey L. Feike · DirectorSince 2024
-
Keow Lin Goh · DirectorSince 2024
- Since 2023
-
Ryan H. Saadi · Director · Chief Executive OfficerSince 2024
-
Scott Harris Sussman · DirectorSince 2023
-
Surendra K. Ajjarapu · Director · CEO and ChairmanSince 2023
-
Susan M. Podlogar · DirectorSince 2024
-
Victor J. Sordillo · DirectorSince 2024
Chief executives
Director election results
Annual meeting of August 24, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
99.6%
Board connections
5 of this board's directors also sit on 7 other boards. 4 are in the same sector.
-
Aspire-Lakewood Holdings Inc. Same sectorvia Avinash R. Wadhwani, Donald G. Fell, Michael L. Peterson and Surendra K. Ajjarapu
- via Avinash R. Wadhwani, Donald G. Fell and Michael L. Peterson
-
DataMeds AI Inc. Same sectorvia Donald G. Fell, Michael L. Peterson and Surendra K. Ajjarapu
-
Scienture Holdings Inc. Same sectorvia Michael L. Peterson and Surendra K. Ajjarapu
- via Michael L. Peterson
-
LivaNova PLC Same sectorvia Susan M. Podlogar
- via Michael L. Peterson
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $6,635
- 3 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 2, 2026 | Ryan H. Saadi Director, Officer (Chief Executive Officer), 10% owner | Grant or award | +50,000,000 | — | — |
| Sep 14, 2026 | Desai Kirti Officer (Chief Financial Officer) | Grant or award | +750,000 | — | — |
| Sep 14, 2026 | Ryan H. Saadi Director, Officer (Chief Executive Officer), 10% owner | Grant or award | +8,000,000 | — | — |
| Sep 11, 2026 | Jeffrey L. Feike Director | Grant or award | +75,000 | — | — |
| Sep 11, 2026 | Keow Lin Goh Director | Grant or award | +75,000 | — | — |
| Sep 11, 2026 | Susan M. Podlogar Director | Grant or award | +75,000 | — | — |
| Sep 11, 2026 | Curtis L. Patton Director | Grant or award | +75,000 | — | — |
| Sep 11, 2026 | Victor J. Sordillo Director | Grant or award | +75,000 | — | — |
| Jul 10, 2026 | Desai Kirti Officer (Chief Financial Officer) | Grant or award | +40,000 | — | — |
| Jul 10, 2026 | Jeffrey L. Feike Director | Grant or award | +40,000 | — | — |
| Jul 10, 2026 | Keow Lin Goh Director | Grant or award | +40,000 | — | — |
| Jul 10, 2026 | Susan M. Podlogar Director | Grant or award | +40,000 | — | — |
| Jul 10, 2026 | Curtis L. Patton Director | Grant or award | +40,000 | — | — |
| Jul 10, 2026 | Ryan H. Saadi Director, Officer (Chief Executive Officer), 10% owner | Grant or award | +1,220,000 | — | — |
| Jul 10, 2026 | Victor J. Sordillo Director | Grant or award | +40,000 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Tevogen Inc.
Who is the CEO of Tevogen Inc.?
Ryan H. Saadi has been Tevogen Inc.'s Chief Executive Officer since February 2024.
How many directors are on Tevogen Inc.'s board?
Tevogen Inc.'s board has 11 directors: Avinash R. Wadhwani, Curtis L. Patton, Donald G. Fell, Jeffrey L. Feike, Keow Lin Goh, Michael L. Peterson, Ryan H. Saadi, Scott Harris Sussman, Surendra K. Ajjarapu, Susan M. Podlogar and 1 other.
Are Tevogen Inc. insiders buying or selling shares?
Over the last 12 months, Tevogen Inc. insiders made no open-market purchases and sold $6,635 of shares in 3 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="tevogen-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.